KCNH2 and breast ductal adenocarcinoma: In Sorlie’s [43] investigation, KCNH2 was upregulated in lobular carcinoma (top 7%) while in the study by Richardson et al. [44], KCNH2 was found to be overexpressed in ductal breast carcinoma (top 21%).